Goodbody Health Limited announced that it has partnered with Datar Cancer Genetics ("Datar") a liquid biopsy company to offer its innovative Circulating Tumor Cell (CTC) based multi-cancer screening solution Trucheck in the UK.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -66.67% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.67% | 3.65K | |
+44.36% | 6.34B | |
-13.52% | 4.61B | |
+10.85% | 3.39B | |
-6.52% | 3.29B | |
+51.14% | 2.02B | |
-5.22% | 1.73B | |
+1.29% | 1.67B | |
+57.69% | 1.63B | |
-9.67% | 1.59B |
- Stock Market
- Equities
- GDBYF Stock
- News Goodbody Health Limited
- Goodbody Health Limited Partners with Datar to Offer Innovative Cancer Screening